A timeline of the week's top headlines

 


Recommended reads from around the web

Recommended For You

Annuitizing your 401(k) (The Wall Street Journal)

Politics and the Supreme Court (The New York Times)


Most read blogs on BenefitsPro this week

Called to the Dean's office, by Denis Storey
You might have heard – since, you know, we're actually promoting it – that left-wing bullhorn Howard Dean will be a featured keynote speaker at Benefits Selling Expo in San Antonio in May.
 
Now that a final resolution has been made on fee and compensation disclosure for ERISA-covered retirement plans, service providers can concentrate on aligning with compliance demands.
 
Last week I took the briefest of looks at the health insurance market and how this controversial empire is carved up amongst the top five power players: Aetna, Anthem, Cigna, Kaiser, and United. Now I want to spend the next few blogs going in depth on these carriers, taking a…
 
Can a popular tactic for hiding fees survive in the era of fee disclosure?
 
Prognostication with taxes is always dangerous, but I'd like to suggest four items businesses should consider in planning for taxes this year—particularly as they apply to benefit planning.
 
Most talked about article on BenefitsPro this week

Most outraged reader on BenefitsPro this week
Louisavalos: "This is woman's right issue and has nothing to do with men. Men are driving this issue that is a woman's decision I don't understand how all these congressmen I mean men can get so fired up on an issue that is total a woman's decision. This not an attack on religious freedom people have the right to say yes or no so get out of the way Congess. Go find a real issue to work or go home." (In response to: Boehner plans birth control reversal)
 
If I missed a news story or you have a good story you'd recommend to other readers, please comment below, and I'll broadcast your suggestion via Twitter.
 
Follow 'This Week in Benefits' on Twitter for daily updates: @BenefitsWeek
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.